Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 25Recruiting 14Active not recruiting 6Unknown 5Not yet recruiting 3Terminated 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

the Rate of Participation in Screening for PBC 1Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 122Carboplatin 121Drug Therapy 118Bevacizumab 105Capecitabine 99Oxaliplatin 97Radiotherapy 95Paclitaxel 88Gemcitabine 88tislelizumab 87Cyclophosphamide 86Specimen Handling 80pembrolizumab 76toripalimab 67Magnetic Resonance Spectroscopy 65Fluorouracil 62sintilimab 59Injections 57Surgical Procedures, Operative 56Docetaxel 54anlotinib 51130-nm albumin-bound paclitaxel 48Immune Checkpoint Inhibitors 47fludarabine 46Standard of Care 45Pemetrexed 43Blood Specimen Collection 43Biopsy 43venetoclax 41lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Mass Screening × Clear all
NCT07206589 2026-04-17

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

Mayo Clinic

Phase NA Not yet recruiting
1,010 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT07027449 2025-06-18

Connecting People With Cancer to Employment Support

University of Kansas Medical Center

Phase NA Not yet recruiting
70 enrolled
Tumor-Agnostic

Neoplasms

NCT05440123 2025-06-12

LUMASCAN-2

Centre Hospitalier Intercommunal Creteil

Not yet recruiting
300 enrolled

the Rate of Participation in Screening for PBC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡